Access: The live webcast can be accessed here and in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days ...
NASA will mark the first day of spring with a satellite telecast about the sun led by an astronomer and some 100 student guests from the San Francisco Bay area. The March 20 broadcast from 10 a.m. to ...
Webcast to be held Wednesday, December 3, at 8:00am ET CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (BDTX), a clinical-stage oncology company developing ...
Introductory webcast for participants to the webcast for participants to the FDA's ASCA, a program in which manufacture.rs may contract with ASCA-accredited test labs to perform testing to certain ...
The National Archery in the Schools Program is popular both nationally and in North Dakota. Learn more about the program and the upcoming state tournament in this week’s “North Dakota Outdoors” ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...
Artificial intelligence (AI) is rapidly transforming the way businesses operate. As AI becomes more pervasive, it is essential for organizations to have a strong AI governance program in place to ...
INDIANAPOLIS, Nov. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Friday, November 20, 2020 to provide an overview of the tirzepatide Phase 3 type 2 diabetes ...
AT&T on Wednesday launched a 24-hour Internet security Webcast program aimed at delivering security alerts and daily dispatches to corporate customers. The company's Internet Security News Network ...
During its Windows 11 Insider Webcast presentation today, a Microsoft employee was spotted running an Intel seventh generation Core processor even though these CPUs are not officially supported. But ...
- Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial and Michael Kelly, PhD, Chief Scientific Officer of CureDuchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results